29 April 2024

Circulars regarding field safety corrective actions regarding pharmaceutical products

Reference: CIR-2024-00000080

To all Health facilities and healthcare practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circular issued by the MOHAP for perusal and adherence to what is stated

Circular No. 3003 for the year 2024 regarding the Recall of one Lot of Pharmaceutical Product Bavencio 20mg/ml

Circular No. 3065 for the year 2024 regarding Voluntary Recall of one lot of pharmaceutical product Glacera 30mg Tablet

Circular No. 3085 for the year 2024 regarding field safety corrective actions

 

 

Thanks in advance for your good co-operation

 

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Bavencio 20mg-ml -++.pdf:

View Document

Glacera 30mg Tablet ++.pdf:

View Document

تقارير سلامة الوسائل الطبية بتاريخ++24-04-2024 (002).pdf:

View Document